Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
Status:
Completed
Trial end date:
2000-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells.
Interferon alfa may interfere with the growth of cancer cells. Combining chemotherapy,
radiation therapy, and interferon alfa may kill more tumor cells.
PURPOSE: Phase I trial to study the effectiveness of cisplatin plus interferon alfa followed
by surgery and interferon alfa plus radiation therapy in treating patients with malignant
pleural mesothelioma.